celastrol methyl ester has been researched along with doxorubicin hydrochloride in 1 studies
| Studies (celastrol methyl ester) | Trials (celastrol methyl ester) | Recent Studies (post-2010) (celastrol methyl ester) | Studies (doxorubicin hydrochloride) | Trials (doxorubicin hydrochloride) | Recent Studies (post-2010) (doxorubicin hydrochloride) |
|---|---|---|---|---|---|
| 39 | 0 | 27 | 277 | 0 | 205 |
| Protein | Taxonomy | celastrol methyl ester (IC50) | doxorubicin hydrochloride (IC50) |
|---|---|---|---|
| RNA polymerase beta subunit (EC 2.7.7.6), partial | Escherichia coli | 14.3747 | |
| 90-kda heat shock protein beta HSP90 beta, partial | Homo sapiens (human) | 0.266 | |
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | 21.2 | |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | 12.7 | |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | 34.6 | |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | 34.6 | |
| heat shock protein HSP 90-alpha isoform 2 | Homo sapiens (human) | 0.266 | |
| 14-3-3 protein gamma | Homo sapiens (human) | 0.7812 | |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | 0.94 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chávez, H; Estévez-Braun, A; Fernández-Pérez, L; Martín-Rodíguez, P; Oramas-Royo, SM; Ravelo, AG | 1 |
1 other study(ies) available for celastrol methyl ester and doxorubicin hydrochloride
| Article | Year |
|---|---|
Cytotoxic triterpenoids from Maytenus retusa.
Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Inhibitory Concentration 50; Maytenus; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Bark; Plants, Medicinal; Triterpenes | 2010 |